RECLAIM - LN, a Phase 2 potentially registrational clinical trial of FT819 in patients with refractory moderate-to-severe ...

Planned Interim Futility Analysis from Pivotal Phase 2 ALPHA3 Trial Supports Cemacabtagene Ansegedleucel’s (Cema-Cel) ...

Cultivated meat startup SuperMeat has raised $6M in fresh financing, as part of a targeted $10M Series A4 round, and filed ...

PDS Biotechnology (NASDAQ:PDSB) reported a smaller first-quarter loss and highlighted changes to its late-stage head and neck ...

ClearPoint Neuro (NASDAQ:CLPT) reported record first-quarter 2026 revenue and reaffirmed its full-year outlook, as management ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 2:20 PM EDTCompany ParticipantsAdam MeyersConference ...

The drug delivery peptide embeds itself in cancer cell membranes and shrinks human tumors in mice more safely than the drug ...

Implantable cytokine factories designed to deliver immunotherapy directly at the site of disease have taken an important step ...

NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next ...